Type IA variation for application Roszdravnadzor-2021-0059. Type IA variation: Formulation Change for Brextanib — routine update

Variation Number
Roszdravnadzor-2021-0059-V259
Type
Type IA
Status
Failed
Fee
€2,639
Submitted
2022-08-21
Approved
—
Description

Type IA variation: Formulation Change for Brextanib — routine update